Post-thrombolytic hyperglycemia and 3-month outcome in acute ischemic stroke

Cerebrovascular Diseases

Volumn 31, Issue 1, 2010, Pages 83-92

  Putaala, Jukka ^c   Sairanen, Tiina ^a,c   Meretoja, Atte ^c   Lindsberg, Perttu J ^a,c   Tiainen, Marjaana ^c   Liebkind, Ron ^c   Strbian, Daniel ^c   Atula, Sari ^c   Artto, Ville ^c   Rantanen, Kirsi ^c   Silvonen, Pyry ^c   Piironen, Katja ^c   Curtze, Sami ^c   Häppölä, Olli ^c   Mustanoja, Satu ^c   Pitkäniemi, Janne ^b   Salonen, Oili ^c   Silvennoinen, Heli ^c   Soinne, Lauri ^c   Kuisma, Markku ^c   Tatlisumak, Turgut ^c   Kaste, Markku ^c   more..

^a Biomedicum Helsinki   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Acute ischemic stroke; Hyperglycemia; Intracerebral hemorrhage; Ischemic stroke; Outcome; Thrombolysis

Indexed keywords

ALTEPLASE; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD SAMPLING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEEDLE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RANKIN SCALE; RISK REDUCTION; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; BLOOD GLUCOSE; BRAIN ISCHEMIA; CHI-SQUARE DISTRIBUTION; FEMALE; FIBRINOLYTIC AGENTS; FINLAND; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INTRACRANIAL HEMORRHAGES; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 78149431412     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321332     Document Type: Article

References (33)

1. Lindsberg PJ, Roine RO: Hyperglycemia in acute stroke. Stroke 2004;35:363-364.
2. Quinn TJ, Lees KR: Hyperglycaemia in acute stroke - To treat or not to treat. Cerebrovasc Dis 2009;27(suppl 1):148-155.
3. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS: Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke. Lancet 1999;353:376-377.
4. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001;32:2426-2432.
5. De Silva DA, Ebinger M, Christensen S, Parsons MW, Levi C, Butcher K, Barber PA, Bladin C, Donnan GA, Davis SM, Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Investigators: Baseline diabetic status and admission blood glucose were poor prognostic factors in the EPITHET trial. Cerebrovasc Dis 2010;29:14-21.
6. Poppe AY, Majumdar SR, Jeerakathil T, Ghali W, Buchan AM, Hill MD, Canadian Alteplase for Stroke Effectiveness Study Investigators: Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diabetes Care 2009;32:617-622.
7. Alvarez-Sabin J, Molina CA, Ribo M, Arenillas JF, Montaner J, Huertas R, Santamarina E, Rubiera M: Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion. Stroke 2004;35:2493-2498.
8. Leigh R, Zaidat OO, Suri MF, Lynch G, Sundararajan S, Sunshine JL, Tarr R, Selman W, Landis DM, Suarez JI: Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy. Stroke 2004;35:1903-1907.
9. Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, Lyden PD, Broderick JP, Kwiatkowski TG, Fineberg SE, NINDS rt-PA Stroke Study Group: Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002;59:669-674.
10. Lindsberg PJ, Soinne L, Roine RO, Salonen O, Tatlisumak T, Kallela M, Häppölä O, Tiainen M, Haapaniemi E, Kuisma M, Kaste M: Community-based thrombolytic therapy of acute ischemic stroke in Helsinki. Stroke 2003;34:1443-1449.
11. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, Tress BM, Davis SM: Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 2002;52:20-28.
12. Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, Colman PG, Chambers BR, Davis SM: Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003;34:2208-2214.
13. Ribo M, Molina CA, Delgado P, Rubiera M, Delgado-Mederos R, Rovira A, Munuera J, Alvarez-Sabin J: Hyperglycemia during ischemia rapidly accelerates brain damage in stroke patients treated with tPA. J Cereb Blood Flow Metab 2007;27:1616-1622.
14. Fuentes B, Castillo J, San Jose B, Leira R, Serena J, Vivancos J, Davalos A, Nunez AG, Egido J, Diez-Tejedor E, Stroke Project of the Cerebrovascular Diseases Study Group, Spanish Society of Neurology: The prognostic value of capillary glucose levels in acute stroke: the Glycemia in Acute Stroke (GLIAS) study. Stroke 2009;40:562-568.
15. Yong M, Kaste M: Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II trial. Stroke 2008;39:2749-2755.
16. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF, American Heart Association/American Stroke Association Stroke Council, American Heart Association/American Stroke Association Clinical Cardiology Council, American Heart Association/American Stroke Association Cardiovascular Radiology and Intervention Council, Atherosclerotic Peripheral Vascular Disease Working Group, Quality of Care Outcomes in Research Interdisciplinary Working Group:: Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007;115: e478-e534.
17. European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee: Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008;25:457-507.
18. Meretoja A, Putaala J, Tatlisumak T, Atula S, Artto V, Curtze S, Häppölä O, Lindsberg PJ, Mustanoja S, Piironen K, Pitkaniemi J, Rantanen K, Sairanen T, Salonen O, Silvennoinen H, Soinne L, Strbian D, Tiainen M, Kaste M: Off-label thrombolysis is not associated with poor outcome in patients with stroke. Stroke 2010;41:1450-1458.
19. Suomalaisen Lääkäriseuran Duodecimin ja Suomen Neurologinen Yhdistys ry:n asettama työryhmä. Käypä Hoito: Aivoinfarkti. (National current therapy guidelines for the management of ischemic stroke). Duodecim 2006;122:2770-2790.
20. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-1587.
21. Wahlgren N, Ahmed N, Davalos A, Hacke W, Millan M, Muir K, Roine RO, Toni D, Lees KR, SITS investigators: Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008;372:1303-1309.
22. Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, Haley EC, Grotta J, Marler J: Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke 1994;25:2220-2226.
23. Quinn TJ, Lees KR, Hardemark HG, Dawson J, Walters MR: Initial experience of a digital training resource for modified Rankin scale assessment in clinical trials. Stroke 2007;38:2257-2261.
24. Kreisel SH, Alonso A, Szabo K, Hennerici MG: Sugar and NICE - Aggressive hyperglycaemic control in ischaemic stroke and what can we learn from non-neurological intensive glucose control trials in the critically ill? Cerebrovasc Dis 2010;29:518-522.
25. Myers MG, Norris JW, Hachniski VC, Sole MJ: Plasma norepinephrine in stroke. Stroke 1981;12:200-204.
26. Kaste M, Somer H, Konttinen A: Heart type creatine kinase isoenzyme (CK MB) in acute cerebral disorders. Br Heart J 1978;40:802-805.
27. Lindsberg PJ, Häppölä O, Kallela M, Valanne L, Kuisma M, Kaste M: Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment. Neurology 2006;67:334-336.
28. Gray CS, Scott JF, French JM, Alberti KG, O'Connell JE: Prevalence and prediction of unrecognised diabetes mellitus and impaired glucose tolerance following acute stroke. Age Ageing 2004;33:71-77.
29. Paciaroni M, Agnelli G, Caso V, Corea F, Ageno W, Alberti A, Lanari A, Micheli S, Bertolani L, Venti M, Palmerini F, Billeci AM, Comi G, Previdi P, Silvestrelli G: Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. Cerebrovasc Dis 2009;28:119-123.
30. Allport LE, Baird TA, Davis SM: Hyperglycaemia and the ischaemic brain: continuous glucose monitoring and implications for therapy. Curr Diabetes Rev 2008;4:245-257.
31. Gray CS, Hildreth AJ, Sandercock PA, O'Connell JE, Johnston DE, Cartlidge NE, Bamford JM, James OF, Alberti KG, GIST Trialists Collaboration: Glucose-potassiuminsulin infusions in the management of poststroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 2007;6:397-406.
32. McCormick M, Hadley D, McLean JR, Macfarlane JA, Condon B, Muir KW: Randomized, controlled trial of insulin for acute poststroke hyperglycemia. Ann Neurol 2010;67:570-578.
33. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hebert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-1297.